Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
AstraZeneca
QuintilesIMS
Healthtrust
Medtronic
Cerilliant
US Army
Deloitte
Argus Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Pergolide mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for pergolide mesylate and what is the scope of pergolide mesylate patent protection?

Pergolide mesylate
is the generic ingredient in two branded drugs marketed by Ivax Sub Teva Pharms, Par Pharm, and Valeant Pharm Intl, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for pergolide mesylate.
Medical Subject Heading (MeSH) Categories for pergolide mesylate

US Patents and Regulatory Information for pergolide mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076061-003 Nov 27, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076094-003 Sep 4, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076061-001 Nov 27, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076094-002 Sep 4, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076061-002 Nov 27, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms PERGOLIDE MESYLATE pergolide mesylate TABLET;ORAL 076094-001 Sep 4, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for pergolide mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Cerilliant
Queensland Health
US Department of Justice
Julphar
Chinese Patent Office
Healthtrust
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot